Industry News
International bio-industry associations join to comment on the USPTO's subject matter eligibility guidance
Biotech industry associations join forces to express concerns about changes to US non-statutory patent law. [ + ]
GI Dynamics recruiting for EndoBarrier utility trial
GI Dynamics (ASX:GID) has signed on the first obese patients for a utility trial of EndoBarrier in France and reported year-on-year revenue growth but a wider net loss for Q1. [ + ]
Crowdfunding to save frogs from pesticides
Researchers from La Trobe University have set up a crowdfunding page to enable research into the exposure of frogs to pesticides. [ + ]
Australian Therapeutic Pipeline to translate health discoveries into clinical application
Therapeutic Innovation Australia (TIA) has launched the Australian Therapeutic Pipeline - a collaborative initiative to better enable Australian researchers to translate their health discoveries into clinical application. [ + ]
Mesoblast MPCs to be trialled in end-stage heart failure
Mesoblast and the US National Institutes of Health will team up for a 120-patient trial of the company's MPCs in end-stage heart failure. [ + ]
$200 million to boost dementia research
The National Health and Medical Research Council (NHMRC) today announced the first steps in its delivery of the Australian Government's $200 million 'Boosting Dementia Research' budget measure. [ + ]
2014 Eureka Prize finalists
Finalists across the spectrum of life sciences, from research in agriculture and infectious diseases to science journalism and photography, have been announced for the 2014 Australian Museum Eureka Prizes. [ + ]
Priorities for Antarctic research outlined
The Scientific Committee on Antarctic Research (SCAR) has convened 75 scientists and policymakers from 22 countries to agree on the priorities for Antarctic research for the next 20 years and beyond. [ + ]
Process shows potential for graphene scale-up
The future looks bright for the use of graphene in the mass production of biocompatible sensor devices with the development of a new microfabrication process. [ + ]
AusBiotech submits to Senate Inquiry into Australia's Innovation System
AusBiotech's substantive submission to the Senate Standing Committee on Economics' Australian Innovation System inquiry has called for tax reform, support for commercialisation, incentives for commercial thinking and clinical trial reform. [ + ]
Immuron's Travelan launches in Canada
Immuron's (ASX:IMC) distribution partner Paladin Labs has launched OTC travellers' diarrhoea treatment Travelan in Canada. [ + ]
New malaria vaccine approach attracts collaboration
A collaboration between the Burnet Institute and ARTES Biotechnology will progress the development of and test a new strategy for a malaria vaccine. [ + ]
AOD9604 awarded safe status in US
Calzada (ASX:CZD) said its peptide AOD9604 has secured Generally Recognised As Safe status in the US, allowing its use in food and supplements at a daily level of up to 1 mg per person. [ + ]
Advancing research in plant energy biology
The launch of the Australian Research Council Centre of Excellence in Plant Energy Biology 2014-2020, will focus on understanding and enhancing plant energy systems to increase crop yields. [ + ]
RV Investigator en route to Hobart
The CSIRO research vessel Investigator is setting sail from Singapore for its new home port of Hobart, where it is expected to arrive by mid-September. The vessel's arrival, which was initially planned for June 2013, will enable the Marine National Facility (MNF) Steering Committee to determine its 2014-15, 2015-16 and 2016-17 voyage scheduling. [ + ]
